Inhibition of heparin-binding epidermal growth factor-like growth factor increases albuminuria in puromycin aminonucleoside nephrosis
- 1 September 2000
- journal article
- Published by Elsevier in Kidney International
- Vol. 58 (3) , 1098-1107
- https://doi.org/10.1046/j.1523-1755.2000.00267.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Heparin-binding epidermal growth factor-like growth factor in experimental models of membranous and minimal change nephropathyKidney International, 1998
- The Membrane-bound Form of Heparin-binding Epidermal Growth Factor-like Growth Factor Promotes Survival of Cultured Renal Epithelial CellsJournal of Biological Chemistry, 1997
- Production of heparin binding epidermal growth factor-like growth factor in the early phase of regeneration after acute renal injury. Isolation and localization of bioactive molecules.Journal of Clinical Investigation, 1997
- Induction of heparin-binding epidermal growth factor-like growth factor mRNA in rat kidney after acute injury.Journal of Clinical Investigation, 1995
- Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites.The Journal of cell biology, 1995
- A nephritogenic rat monoclonal antibody to mouse aminopeptidase A. Induction of massive albuminuria after a single intravenous injection.The Journal of Experimental Medicine, 1992
- Stable cell line of T-SV40 immortalized human glomerular visceral epithelial cellsKidney International, 1991
- Polymorphism of the complement receptor for C3bi.Journal of Clinical Investigation, 1985
- An ultrastructural study of the mechanisms of proteinuria in aminonucleoside nephrosisKidney International, 1975
- Enzyme-linked immunosorbent assay (ELISA) quantitative assay of immunoglobulin GImmunochemistry, 1971